Jennifer Onyekonwu-Mcgill, NP

NPI: 1063686616
Total Payments
$17,921
2024 Payments
$4,945
Companies
29
Transactions
882
Medicare Patients
477
Medicare Billing
$93,549

Payment Breakdown by Category

Food & Beverage$17,586 (98.1%)
Education$316.29 (1.8%)
Travel$18.70 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $17,586 872 98.1%
Education $316.29 9 1.8%
Travel and Lodging $18.70 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $4,144 178 $0 (2024)
Alkermes, Inc. $1,823 64 $0 (2024)
Janssen Pharmaceuticals, Inc $1,488 67 $0 (2024)
Otsuka America Pharmaceutical, Inc. $1,451 82 $0 (2024)
ABBVIE INC. $1,305 63 $0 (2024)
Lundbeck LLC $1,210 71 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,163 95 $0 (2024)
Neurocrine Biosciences, Inc. $930.56 36 $0 (2024)
ITI, Inc. $780.84 44 $0 (2023)
Sunovion Pharmaceuticals Inc. $691.64 39 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,945 232 Teva Pharmaceuticals USA, Inc. ($1,376)
2023 $4,785 243 Teva Pharmaceuticals USA, Inc. ($1,205)
2022 $4,845 250 Teva Pharmaceuticals USA, Inc. ($1,210)
2021 $3,346 157 Takeda Pharmaceuticals U.S.A., Inc. ($409.95)

All Payment Transactions

882 individual payment records from CMS Open Payments — Page 1 of 36

Date Company Product Nature Form Amount Type
12/18/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $27.73 General
Category: Neuropsychiatry
12/18/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $17.69 General
Category: PSYCHIATRY
12/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.62 General
Category: NEUROSCIENCE
12/16/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $7.37 General
Category: PSYCHIATRY
12/16/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $6.66 General
Category: NEUROSCIENCE
12/11/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $25.54 General
Category: PSYCHIATRY
12/10/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $20.92 General
Category: CNS
12/10/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $20.71 General
Category: Neurology
12/09/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $21.29 General
Category: Central Nervous System
12/02/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $34.51 General
Category: PSYCHIATRY
11/20/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $21.58 General
Category: CNS
11/19/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $18.87 General
Category: Neurology
11/18/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $23.78 General
Category: PSYCHIATRY
11/18/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $9.71 General
Category: NEUROSCIENCE
11/18/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $6.59 General
Category: PSYCHIATRY
11/18/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $6.34 General
Category: PSYCHIATRY
11/13/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $21.30 General
Category: PSYCHIATRY
11/12/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $18.98 General
Category: Psychiatry/Psychology
11/12/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $7.31 General
Category: Central Nervous System
11/11/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $14.48 General
11/04/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $27.05 General
Category: VILOXAZINE HYDROCHLORIDE
11/04/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $6.99 General
Category: PSYCHIATRY
10/29/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $4.13 General
Category: Central Nervous System
10/24/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $24.08 General
Category: Neurology
10/23/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $18.58 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 108 300 $71,050 $19,886
2022 4 124 350 $89,416 $27,777
2021 4 130 363 $89,280 $27,454
2020 3 115 338 $84,850 $18,431
Total Patients
477
Total Services
1,351
Medicare Billing
$93,549
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 50 182 $45,500 $14,869 32.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 45 105 $21,000 $3,925 18.7%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 13 13 $4,550 $1,093 24.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 70 289 $72,250 $21,685 30.0%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 21 21 $7,350 $2,685 36.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 16 18 $5,416 $2,207 40.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 17 22 $4,400 $1,200 27.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 76 304 $75,775 $23,111 30.5%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 27 27 $9,450 $3,405 36.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 14 19 $3,800 $895.01 23.6%
96127 Brief emotional or behavioral assessment Office 2021 13 13 $255.00 $42.90 16.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 60 273 $68,250 $14,942 21.9%
90792 Psychiatric diagnostic evaluation with medical services Office 2020 24 24 $8,400 $2,456 29.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 31 41 $8,200 $1,033 12.6%

About Jennifer Onyekonwu-Mcgill, NP

Jennifer Onyekonwu-Mcgill, NP is a Registered Nurse healthcare provider based in Claremont, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1063686616.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Onyekonwu-Mcgill, NP has received a total of $17,921 in payments from pharmaceutical and medical device companies, with $4,945 received in 2024. These payments were reported across 882 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($17,586).

As a Medicare-enrolled provider, Onyekonwu-Mcgill has provided services to 477 Medicare beneficiaries, totaling 1,351 services with total Medicare billing of $93,549. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Registered Nurse
  • Other Specialties Family, Psychiatric/Mental Health
  • Location Claremont, CA
  • Active Since 04/15/2008
  • Last Updated 09/22/2021
  • Taxonomy Code 163W00000X
  • Entity Type Individual
  • NPI Number 1063686616

Products in Payments

  • AUSTEDO (Drug) $1,708
  • REXULTI (Drug) $1,519
  • VRAYLAR (Drug) $1,305
  • UZEDY (Drug) $1,284
  • INVEGA SUSTENNA (Drug) $1,281
  • ARISTADA (Drug) $1,219
  • CAPLYTA (Drug) $1,190
  • TRINTELLIX (Drug) $1,163
  • Austedo XR (Drug) $970.93
  • INGREZZA (Drug) $930.56
  • LATUDA (Drug) $691.64
  • ABILIFY MAINTENA (Drug) $590.82
  • LYBALVI (Drug) $587.58
  • PERSERIS (Drug) $582.08
  • ABILIFY ASIMTUFII (Drug) $360.19
  • HETLIOZ (Drug) $306.45
  • QELBREE (Drug) $209.39
  • SPRAVATO (Drug) $207.53
  • Auvelity (Drug) $191.89
  • Azstarys (Drug) $163.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Registered Nurse Doctors in Claremont